Amy Labar
Clinical FellowAbout
Copy Link
Titles
Clinical Fellow
Biography
Amy was born and raised New York City. She received an undergraduate degree from Haverford College and a Master’s in Public Health focused on Global Health at Harvard School of Public Health. After time working with Medecins Sans Frontieres/Epicentre and International Rescue Committee, she returned to medical school at Columbia University. She completed her internal medicine residency at the University of Pittsburgh Medical Center and then joined Yale as a clinical fellow. Her professional interests include global health, asylum medicine, and critical care. Outside of work, she enjoys running, traveling, and trying new restaurants.
Departments & Organizations
- All Institutions
- Internal Medicine
- PCCM Fellows
- Yale Center for Asylum Medicine
Education & Training
- Residency
- University of Pittsburgh Medical Center (2024)
- MD
- Columbia University Vagelos College of Physicians and Surgeons (2021)
- MS
- Harvard T.H. Chans School of Public Heath, Global Health & Popluation (2014)
Board Certifications
Internal Medicine
- Certification Organization
- ABIM
- Original Certification Date
- 2025
Research
Copy Link
Overview
Yale School of Medicine and Yale School of Public Health, New Haven, CT Jul 2025-Present
Post-Doctoral Fellow, Division of Pulmonary, Critical Care, and Sleep Medicine, Supervised by Dr. Luke
Davis
• Studying post-TB lung disease screening in primary care setting in Uganda
Research at a Glance
Yale Co-Authors
Charles Dela Cruz, MD, PhD
Publications
2025
Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure
Labar A, Ulrich B, Lovelace T, Bain W, Shah F, White E, Abe E, Giacona F, Alba G, Thompson B, Schmidt E, Zuchelkowski B, Evankovich J, Yang H, Ramanan R, Murray H, Haidar G, Snyder M, Qin S, Wang X, Zhang Y, Nouraie S, Dela Cruz C, Turnquist H, Ray P, Ray A, Methé B, Benos P, Morris A, McVerry B, Alladina J, Kitsios G. Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure. Critical Care Medicine 2025, 53: e1567-e1580. PMID: 40402026, DOI: 10.1097/ccm.0000000000006716.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAcute respiratory failurePlasma sST2 levelsExtrapulmonary organ dysfunctionLower respiratory tractAcute respiratory failure patientsSST2 levelsSoluble ST2Organ dysfunctionRespiratory failureMulticenter cohortPlasma levelsEtiology of acute respiratory failureAcute respiratory failure etiologiesWeek of critical illnessLower respiratory tract specimensPlasma soluble ST2Soluble ST2 levelsDiverse cohort of patientsSystemic host responseIndividual organ dysfunctionIL-33/ST2 axisCohort of patientsAdverse clinical outcomesMultiple organ dysfunctionPooled cohort dataThree hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validation.
Stringer WS, Labar AS, Geleris JD, Sholle EV, Berlin DA, McGroder CM, Cummings MJ, O'Donnell MR, Yi H, Yang X, Wei Y, Schenck EJ, Baldwin MR. Three hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validation. PLoS One 2025, 20: e0316434. PMID: 40106751, DOI: 10.1371/journal.pone.0316434.Peer-Reviewed Original Research
2020
Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus
Zelnick JR, Daftary A, Hwang C, Labar AS, Boodhram R, Maharaj B, Wolf AK, Mondal S, Amico KR, Orrell C, Seepamore B, Friedland G, Padayatchi N, O’Donnell MR. Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus. Clinical Infectious Diseases 2020, 73: e1901-e1910. PMID: 33053186, PMCID: PMC8492155, DOI: 10.1093/cid/ciaa1557.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAntiretroviral therapyAdherent patientsTreatment challengesHigh riskDetectable HIV viral loadHuman immunodeficiency virus (HIV) epidemicBedaquiline-containing regimensMore adherent patientsHIV viral loadAdherence support interventionsDrug-resistant tuberculosisHuman immunodeficiency virusSubpopulation of patientsHigh-risk subpopulationsElectronic dose monitoring devicesMental health issuesHIV patientsBaseline characteristicsTreatment failureViral loadImmunodeficiency virusPoor outcomeProspective studyLow adherenceTreatment outcomes
News
Copy Link
Get In Touch
Copy Link